Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
It is indicated for intramuscular or deep subcutaneous use to treat vitamin B deficiencyoften seen in pernicious anemia or malabsorption syndromes
Many medications are often prescribed off-label for conditions that exceed their original FDA approval
In the Phase 3 REDEFINE 1 trial, CagriSema produced a mean body weight reduction of approximately 22.7% from baseline at 68 weeks in adults with obesity (without type 2 diabetes)
Do not use while pregnant or nursing without medical guidance
US$ 25.34
US$ 26.77
US$ 25.62
